XML 83 R98.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Subsequent Events (Details) - Progenics Pharmaceuticals - USD ($)
$ in Millions
Feb. 20, 2020
Oct. 01, 2019
Subsequent Event [Line Items]    
Common stock portion, number of stock for each share of progenics common stock (in shares)   0.2502
Ownership percentage   35.00%
Subsequent Event    
Subsequent Event [Line Items]    
Common stock portion, number of stock for each share of progenics common stock (in shares) 0.31  
Aggregate cash payments percentage 40.00%  
Ownership percentage 40.00%  
Cash Payments, 2022 | Subsequent Event    
Subsequent Event [Line Items]    
Aggregate cash payments $ 100  
Cash Payments, 2023 | Subsequent Event    
Subsequent Event [Line Items]    
Aggregate cash payments $ 150  
Maximum | Subsequent Event    
Subsequent Event [Line Items]    
Percentage of total consideration 19.90%